Pages that link to "Q24609215"
Jump to navigation
Jump to search
The following pages link to 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro (Q24609215):
Displaying 50 items.
- A reflection on HIV/AIDS research after 25 years (Q21245200) (← links)
- Reverse transcription of the HIV-1 pandemic (Q22242815) (← links)
- Peptides that bind the HIV-1 integrase and modulate its enzymatic activity--kinetic studies and mode of action (Q24316120) (← links)
- Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus (Q24619823) (← links)
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase (Q24629039) (← links)
- Pathogenesis of human immunodeficiency virus infection (Q24634681) (← links)
- Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A (Q24649411) (← links)
- Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin (Q24652927) (← links)
- The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic (Q24655011) (← links)
- The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle (Q24685965) (← links)
- Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders (Q26748728) (← links)
- An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014 (Q26771734) (← links)
- Role of Marine Natural Products in the Genesis of Antiviral Agents (Q26796360) (← links)
- Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies (Q27485071) (← links)
- Structural basis for activation of α-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase (Q27625384) (← links)
- Structural and functional consequences of single amino acid substitutions in the pyrimidine base binding pocket of Escherichia coli CMP kinase (Q27645128) (← links)
- HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism (Q27676835) (← links)
- P2' Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2 bis-Tetrahydrofuran Moiety (Q27679177) (← links)
- Approved Antiviral Drugs over the Past 50 Years (Q27755387) (← links)
- HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate (Q28250395) (← links)
- The design of drugs for HIV and HCV (Q28259321) (← links)
- The renaissance of fixed dose combinations: Combivir (Q28279752) (← links)
- 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcri (Q28316183) (← links)
- (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro (Q28316326) (← links)
- Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion (Q28316430) (← links)
- Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine (Q28318354) (← links)
- In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations (Q28318476) (← links)
- The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro (Q28319933) (← links)
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives (Q28323202) (← links)
- In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors (Q28323307) (← links)
- Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus (Q28323353) (← links)
- Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases (Q28323369) (← links)
- Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases (Q28323433) (← links)
- The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivatives (Q28323456) (← links)
- Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3'-azidothymidine triphosphate (Q28323481) (← links)
- Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses (Q28323510) (← links)
- Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate (Q28323550) (← links)
- Synergistic Inhibition of Human Immunodeficiency Virus Replication In Vitro by Combinations of 3′-Azido-3′-Deoxythymidine and 3′-Fluoro-3′-Deoxythymidine (Q28323570) (← links)
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor (Q28323582) (← links)
- An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives (Q28323682) (← links)
- Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase (Q28323712) (← links)
- Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA.RNA hybridization (Q28323773) (← links)
- Inhibition of Human Immunodeficiency Virus (HTV-1) Replication In Vitro by Noncytotoxic Doses of Camptothecin, a Topoisomerase I Inhibitor (Q28323784) (← links)
- BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine (Q28323825) (← links)
- Phosphatidylazidothymidine. Mechanism of antiretroviral action in CEM cells (Q28323864) (← links)
- Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine (Q28324208) (← links)
- In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine (Q28324338) (← links)
- Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine (Q28326866) (← links)
- AZT-induced mitochondrial myopathy (Q28327176) (← links)
- Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives (Q28328852) (← links)